Diferencia entre revisiones de «EBQ:Sgarbossa Criteria Study»

Sin resumen de edición
Sin resumen de edición
Línea 13: Línea 13:
| fulltexturl= http://www.nejm.org/doi/full/10.1056/NEJM199602223340801
| fulltexturl= http://www.nejm.org/doi/full/10.1056/NEJM199602223340801
| pdfurl=http://www.nejm.org/doi/pdf/10.1056/NEJM199602223340801
| pdfurl=http://www.nejm.org/doi/pdf/10.1056/NEJM199602223340801
| status=Under Review
}}
}}
==Clinical Question==
==Clinical Question==
Línea 66: Línea 67:


[[Category:EBQ]]
[[Category:EBQ]]
[[Category:Cards]]

Revisión del 14:00 11 abr 2014

Under Review Journal Club Article
Sgarbossa E. et al.. "Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators". NEJM. 1996. 334(8):481-7.
PubMed Full text PDF

Clinical Question

How can we Diagnose Acute Myocardial Infarction in Left Bundle Branch Block patients ?

Conclusion

A Validated Clinical prediction rule has been Developed based on ECG criteria to Diagnose Acute Myocardial infarction in Left Bundle Branch Patients

Major Points

  1. ST-segment Elevation of at least 1 mm with concordance with the QRS complex
  2. ST-segment depression in leads V1, V2 or V3
  3. ST-segment Elevation of atleast 5 mm with discordance with the QRS complex

Study Design

Population

Patient Demographics

  • Median Age: 68 years
  • Males: 64% in study group and 60% in experimental group
  • Left Axis Deviation: 28% Vs. 48%
  • Previous MI: 26% Vs. 59%

Inclusion Criteria

Patients with LBBB

Exclusion Criteria

Interventions

Outcomes

Primary Outcome

Acute Myocardial Infarction

Secondary Outcomes

Subgroup analysis

Criticisms & Further Discussion

Funding

Grant from Bayer, Genentech, CIBA–Corning, ICI Pharmaceuticals, and Sanofi Pharmaceuticals.

Sources